
SBRT for Prostate Cancer: Understanding the Evidence of the PACE-B Trial
“Stereotactic body radiation therapy (SBRT) for patients with low and favorable intermediate risk prostate cancer should be considered a new standard of care,” reports Prof.
Bringing you the perspectives of Accuray and healthcare experts in the world of radiation therapy. Find out what’s happening in the industry, read inspirational stories, and learn more.
“Stereotactic body radiation therapy (SBRT) for patients with low and favorable intermediate risk prostate cancer should be considered a new standard of care,” reports Prof.
At ASTRO 2022 over 1,600 abstracts were accepted, representing all aspects of oncology and radiation therapy for oncologic and non-oncologic conditions. The extensive breadth and
Clinical teams around the globe are using the CyberKnife® Treatment Delivery System to open up new possibilities in ultra-hypofractionated radiation therapy for prostate cancer patients.
Sign up, and we’ll send you an email each time a new blog is published
Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.
Your go-to source for staying informed about our advancements.
Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.